JAMA Current Issue

Active Monitoring for Low-Risk Ductal Carcinoma In Situ

To the Editor The COMET trial compared active monitoring with guideline-concordant care in patients with low-risk ductal carcinoma in situ (DCIS).

Jun 10, 2025 - 17:15
 0
To the Editor The COMET trial compared active monitoring with guideline-concordant care in patients with low-risk ductal carcinoma in situ (DCIS).
Read More

Tags:

Previous Article

Why Sense of Smell Could Be a Marker for Mortality Risk

Next Article

Maternal Screening for Congenital Syphilis

Related Posts

JAMA

May 12, 2025  0

The Next Chapter of the Regulation of Health and Health...

May 27, 2025  0

One Million New Pediatric HIV Cases Predicted If PEPFAR...

Jun 10, 2025  0